Ophthorobotics Overview

Founded 2014
Status Private
Employees 4
Latest Deal Type Accelerator/​Inc
Latest Deal Amount $30K
Latest Deal Amount
Investors 2

Ophthorobotics General Information


Developer of medical robotics designed to administer high-precision injections into the eye. The company's medical robotics helps to inject drugs straight into the eye for the treatment of several chronic ophthalmic diseases and also provides and also provides an iris scanner that can ID the patient and continuously track the eye to ensure precision, enabling medical institutions to increase safety for patients, increase availability of procedure, decrease procedure times, allows for integrated data storage and documentation, and reduces costs for medical staff and expensive operating rooms.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • Tannenstrasse 3
  • CLA H7
  • 8092 Zurich
  • Switzerland
+41 044 000 00 00

Ophthorobotics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ophthorobotics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 09-Feb-2017 $30K Completed Startup
1. Grant 01-Jan-2017 00000 Completed Startup

Ophthorobotics Executive Team (3)

Name Title Board Seat Contact Info
Franziska Ullrich Ph.D Co-Founder & Co-Chief Executive Officer
Matthias Becker MD Co-Chief Executive Officer & Medical and Regulatory Advisor
Stephan Michels MD Co-Founder, Chief Medical Officer and Chief Business Development Officer

Ophthorobotics Investors (2)

To view Ophthorobotics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Venture Kick Accelerator/Incubator 000 0000 000000 0
Novartis Corporation 000 0000 000000 0

Ready to get started?

Request a free trial